{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:40:22Z","timestamp":1782780022111,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH-NIAID","award":["1RO1AI130056-01"],"award-info":[{"award-number":["1RO1AI130056-01"]}]},{"name":"80:20 research grant from the Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00284-018-1491-3","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T11:21:28Z","timestamp":1523532088000},"page":"1062-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies"],"prefix":"10.1007","volume":"75","author":[{"given":"Brianne","family":"Zapata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danya N.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Farah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Garcia-de-la-Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Miro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendra N.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"1491_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"LM Baddour","year":"2015","unstructured":"Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O\u2019Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132:1435\u20131486","journal-title":"Circulation"},{"issue":"1","key":"1491_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/AAC.02071-15","volume":"60","author":"AD Berti","year":"2015","unstructured":"Berti AD, Theisen E, Sauer J-D, Nonejuie P, Olson J, Pogliano J, Sakoulas G, Nizet V, Proctor RA, Rose WE (2015) Penicillin binding protein-1 is important in the compensatory response of Staphylococcus aureus to daptomycin-induced membrane damage and is a potential target for \u03b2-lactam-daptomycin synergy. Antimicrob Agents Chemother 60(1):451\u2013458","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR3","volume-title":"Performance standards for antimicrobial susceptibility testing: approved standard M100-S16","author":"CLSI","year":"2006","unstructured":"CLSI (2006) Performance standards for antimicrobial susceptibility testing: approved standard M100-S16. CLSI, Wayne"},{"key":"1491_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1128\/AAC.40.4.891","volume":"40","author":"GV Doern","year":"1996","unstructured":"Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL (1996) Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 40:891\u2013894","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR5","first-page":"330","volume-title":"Antibiotics in laboratory medicine","author":"G Eliopoulos","year":"1996","unstructured":"Eliopoulos G, Moellering R (1996) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine. William and Wilkins Co., Baltimore, pp\u00a0330\u2013396"},{"issue":"2","key":"1491_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jac\/dkl219","volume":"58","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Manta KG, Ntziora F, Vardakas KZ (2006) Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 58(2):273\u2013280","journal-title":"J Antimicrob Chemother"},{"key":"1491_CR7","first-page":"990","volume-title":"Principles and practices of infectious diseases","author":"VG Fowler","year":"2015","unstructured":"Fowler VG, Scheld WM, Bayer AS (2015) Endocarditis and intravascular infections. In: Bennett JE, Dolin R, Blaser MJ (eds) Principles and practices of infectious diseases. Elsevier, Amsterdam, pp\u00a0990\u20131028"},{"key":"1491_CR8","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1128\/AAC.00141-11","volume":"55","author":"U Furustrand Tafin","year":"2011","unstructured":"Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, Trampuz A (2011) Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 55:4821\u20134827","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR9","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1128\/AAC.01921-12","volume":"57","author":"C Garc\u00eda-de-la-M\u00e0ria","year":"2013","unstructured":"Garc\u00eda-de-la-M\u00e0ria C, Pericas JM, R\u00edo AD, Casta\u00f1eda X, Armero XVY, Espinal PA, Cervera C, Soy D, Falces C, Ninot S, Almela M, Mestres CA, Gatell JM, Vila J, Moreno A, Marco F, Mir\u00f3 JM, the Hospital Clinic Experimental Endocarditis Study Group (2013) Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group of streptococci after exposure to daptomycin. Antimicrob Agents Chemother 57:2319\u20132325","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jac\/46.1.79","volume":"46","author":"HH Houlihan","year":"2000","unstructured":"Houlihan HH, Stokes DP, Rybak MJ (2000) Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model. J Antimicrobial Chemother 46:79\u201386","journal-title":"J Antimicrobial Chemother"},{"key":"1491_CR11","volume-title":"Clinical microbiology procedures handbook","author":"HD Isenberg","year":"2004","unstructured":"Isenberg HD (2004) Clinical microbiology procedures handbook. ASM Press, Washington, DC"},{"issue":"8","key":"1491_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2146\/ajhp130482","volume":"71","author":"JJ Kisgen","year":"2014","unstructured":"Kisgen JJ, Mansour H, Unger NR, Childs LM (2014) Tedizolid: a new oxazolidinone antimicrobial. Am J Health Syst Pharm 71(8):621\u2013633","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"1491_CR13","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1086\/518174","volume":"44","author":"B Knoll","year":"2007","unstructured":"Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM (2007) Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis 44(12):1585\u20131592","journal-title":"Clin Infect Dis"},{"key":"1491_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/321910","volume":"33","author":"CS Levy","year":"2001","unstructured":"Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR (2001) Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin Infect Dis 33:577\u2013579","journal-title":"Clin Infect Dis"},{"key":"1491_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10156-012-0465-9","volume":"19","author":"N Matsui","year":"2013","unstructured":"Matsui N, Ito M, Kuramae H, Inukai T, Sakai A, Okugawa M (2013) Infective endocarditis caused by multidrug-resistant Streptococcus mitis in a combined immunocompromised patient: an autopsy case report. J Infect Chemother 19:321\u2013325","journal-title":"J Infect Chemother"},{"key":"1491_CR16","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1128\/AAC.01525-12","volume":"56","author":"S Mehta","year":"2012","unstructured":"Mehta S, Singh C, Plata KB, Chanda PK, Paul A, Riosa S, Rosato RR, Rosato AE (2012) Beta-lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives. Antimicrob Agents Chemother 56:6192\u20136200","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR17","unstructured":"Mishra NN, Alvarez DN, Garcia-de-la-Maria C, Pericas JM, Moreno A, Marco F, Vila X, Miro JM, Bayer AS (2014) Cell membrane (CM) characteristics of in vitro-selected high-level daptomycin-resistant (DAP-R) strains of Streptococcus mitis. In: Proceedings of interscience conference on antimicrobial agents and chemotherapy (ICAAC), Washington, DC"},{"key":"1491_CR18","doi-asserted-by":"publisher","first-page":"e02435-16","DOI":"10.1128\/AAC.02435-16","volume":"61","author":"NN Mishra","year":"2017","unstructured":"Mishra NN, Tran TT, Seepersaud R, Garcia-de-la-Maria C, Faull K, Yoon A, Miro JM, Rybak MJ, Bayer AS, Arias CA, Sullam PM (2017) Perturbations of phosphatidate cytidylyltransferase (CdsA) mediate daptomycin resistance in Streptococcus mitis by a novel mechanism. Antimicrobial Agents Chemother 61:e02435-16","journal-title":"Antimicrobial Agents Chemother"},{"key":"1491_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.2041-1014.2010.00601.x","volume":"26","author":"J Mitchell","year":"2011","unstructured":"Mitchell J (2011) Streptococcus mitis: walking the line between commensalism and pathogenesis. Molecular Oral Microbiol 26:89\u201398","journal-title":"Molecular Oral Microbiol"},{"key":"1491_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0601-x","author":"C Roger","year":"2017","unstructured":"Roger C, Roberts JA, Muller L (2017) Clinical pharmacokinetics and pharmacodynamics of oxazolidinones. Clin Pharmacokinet. \nhttps:\/\/doi.org\/10.1007\/s40262-017-0601-x","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1491_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1128\/AAC.05551-11","volume":"56","author":"G Sakoulas","year":"2012","unstructured":"Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA (2012) Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 56(2):838\u2013844","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR22","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/cncr.21801","volume":"106","author":"A Safdar","year":"2006","unstructured":"Safdar A, Rolston KV (2006) Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer. Cancer 106:1815\u20131820","journal-title":"Cancer"},{"key":"1491_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/jac\/dki032","volume":"55","author":"JM Streit","year":"2005","unstructured":"Streit JM, Steenbergen JN, Thorne GM, Alder J, Jones RN (2005) Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 55:574\u2013578","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1491_CR24","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1517\/13543784.8.8.1223","volume":"8","author":"FP Tally","year":"1999","unstructured":"Tally FP, Zeckel M, Wasilewski MM, Carini C, Berman CL, Drusano GL, Oleson FB Jr (1999) Daptomycin: a novel agent for Gram-positive infections. Expert Opin Investig Drugs 8(8):1223\u20131238","journal-title":"Expert Opin Investig Drugs"},{"issue":"3\u20134","key":"1491_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijmm.2013.10.004","volume":"304","author":"N Vinay Kumar","year":"2014","unstructured":"Vinay Kumar N, van der Linden M, Menon T, Nitsche-Schmitz DP (2014) Viridans and bovis group streptococci that cause infective endocarditis in two regions with contrasting epidemiology. Int J Med Microbiol 304(3\u20134):262\u2013268","journal-title":"Int J Med Microbiol"},{"issue":"Suppl 3","key":"1491_CR26","first-page":"iii25","volume":"62","author":"RE Warren","year":"2008","unstructured":"Warren RE (2008) Daptomycin in endocarditis and bacteraemia: a British perspective. J Antimicrob Chemother 62(Suppl 3):iii25\u2013iii33","journal-title":"J Antimicrob Chemother"},{"key":"1491_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1128\/AAC.01586-12","volume":"57","author":"BJ Werth","year":"2013","unstructured":"Werth BJ, Sakoulas G, Rose WE, Pogliano J, Ryan T, Ryabak MJ (2013) Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model. Antimicrob Agents Chemother 57:66\u201373","journal-title":"Antimicrob Agents Chemother"},{"key":"1491_CR28","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1469-0691.2004.00975.x","volume":"10","author":"K Westling","year":"2004","unstructured":"Westling K, Julander I, Ljungman P, Heimdahl A, Thalme A, Nord CE (2004) Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease. Clin Microbiol Infect 10:899\u2013903","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1491_CR29","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1128\/AAC.00487-10","volume":"54","author":"SJ Yang","year":"2010","unstructured":"Yang SJ, Xiong YQ, Boyle-Vavra S, Daum R, Jones T, Bayer AS (2010) Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the \u201cseesaw effect\u201d). Antimicrob Agents Chemother 54(8):3161\u20133169","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"1491_CR30","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/jac\/dkx130","volume":"72","author":"J Yim","year":"2017","unstructured":"Yim J, Smith JR, Singh NB, Rice S, Stamper K, Garcia de la Maria C, Bayer AS, Mishra NN, Mir\u00f3 JM, Tran TT, Arias CA, Sullam P, Rybak MJ (2017) Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs). J Antimicrob Chemother 72(8):2290\u20132296","journal-title":"J Antimicrob Chemother"},{"key":"1491_CR31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2165\/00003495-200969070-00003","volume":"69","author":"GG Zhanel","year":"2009","unstructured":"Zhanel GG, Sniezek G, Schweizer F, Zelenitsky S,\u00a0Lagac\u00e9-Wiens PR,\u00a0Rubinstein E,\u00a0Gin AS,\u00a0Hoban DJ,\u00a0Karlowsky JA (2009) Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus. Drugs 69:809\u2013831","journal-title":"Drugs"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-018-1491-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-018-1491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-018-1491-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T06:16:27Z","timestamp":1586326587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-018-1491-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1007\/s00284-018-1491-3","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"5 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}